Advertisement

Open Access

Transparent Process

DIAPH3 governs the cellular transition to the amoeboid tumour phenotype

Martin H. Hager, Samantha Morley, Diane R. Bielenberg, Sizhen Gao, Matteo Morello, Ilona N. Holcomb, Wennuan Liu, Ghassan Mouneimne, Francesca Demichelis, Jayoung Kim, Keith R. Solomon, Rosalyn M. Adam, William B. Isaacs, Henry N. Higgs, Robert L. Vessella, Dolores Di Vizio, Michael R. Freeman

Author Affiliations

  1. Martin H. Hager1,2,15,,
  2. Samantha Morley1,2,,
  3. Diane R. Bielenberg2,3,
  4. Sizhen Gao4,
  5. Matteo Morello1,2,5,
  6. Ilona N. Holcomb6,
  7. Wennuan Liu7,
  8. Ghassan Mouneimne4,
  9. Francesca Demichelis8,9,
  10. Jayoung Kim1,2,5,
  11. Keith R. Solomon1,10,
  12. Rosalyn M. Adam1,2,
  13. William B. Isaacs11,
  14. Henry N. Higgs12,
  15. Robert L. Vessella13,
  16. Dolores Di Vizio1,2,5 and
  17. Michael R. Freeman (michael.freeman{at}cshs.org) *,1,2,5,14
  1. 1Urological Diseases Research Center, Children's Hospital Boston, Boston, MA, USA
  2. 2Department of Surgery, Harvard Medical School, Boston, MA, USA
  3. 3Vascular Biology Program, Children's Hospital Boston, Boston, MA, USA
  4. 4Department of Cell Biology, Harvard Medical School, Boston, MA, USA
  5. 5Division of Cancer Biology and Therapeutics, Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical Center, Los Angeles, CA, USA
  6. 6Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
  7. 7Center for Cancer Genomics, Wake Forest University, Winston‐Salem, NC, USA
  8. 8Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA
  9. 9Centre for Integrative Biology, University of Trento, Trento, Italy
  10. 10Department of Orthopaedic Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA
  11. 11Department of Urology and Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA
  12. 12Department of Biochemistry, Dartmouth Medical School, Hanover, NH, USA
  13. 13Department of Urology, University of Washington, Seattle, WA, USA
  14. 14Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA
  15. 15Present address: R&D Division, Oncology Research Laboratories, Daiichi Sankyo Europe, Munich, Germany
  1. *Tel: +1 310 423 7069; Fax: +1 310 423 0139
  1. These authors contributed equally to this work.

View Full Text